The Caring Ambassadors Program uses a unique approach in our work to address the elimination of viral hepatitis and specifically hepatitis C.
Our three main methods to combat hepatitis C are to Empower patients and providers to increase their knowledge of hepatitis C to improve access a cure; to Educate systems and communities on how to integrate viral hepatitis services into existing programming; and to Advocate on behalf of patients and communities to create sound policy, funding and messaging. We are honored to serve the community to help eliminate the largest infectious disease outbreak of our time; we promise to be BOLD in our approach to creating paths to health and making hepatitis C history.
Join Us In Salem, OR
Hepatitis Elimination Day!
We need a solid showing in order to secure the money the state needs to treat everyone with hepatitis C.
We have tables available for groups that want to display their work
Are you part of the Elimination movement?
Get Tested! Get Cured!
Days to Hepatitis C Elimination.
Goal to Eliminate HCV 2030 will be ‘narrowly’ missed
“As defined by WHO targets, the goal to eliminate hepatitis C virus globally by 2030 will be “narrowly missed,” but is possible by 2032 using new tools and “ambitious, integrated interventions,” study findings showed.”
OxyContin reformulation to curb opioid abuse led to hepatitis C surge, study finds
“Reformulation of the pain medicine OxyContin in 2010 to make it more difficult to abuse directly led to a large rise in hepatitis C infections as drug abusers switched from the prescription medication to injectable heroin, according to a new RAND Corporation study.”
A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C
“The hepatitis C virus is responsible for more deaths in the United States than any other infectious disease, and hepatitis C infections have been rising at an alarming rate since 2010. We evaluated the role of the opioid epidemic and, in particular, the 2010 introduction of an abuse-deterrent version of OxyContin.”
To tackle addiction, the French look beyond drugs to care for the person
“France finds that in order to reach people who use drugs, they first need to have a place where they’re comfortable enough to relax. This story is part of a series exploring harm reduction strategies and drug policies that have been successful in Western Europe.”
Sen. Wiener Reintroduces Bill Pushing For Safe Injection Sites
“State Sen. Scott Wiener, D-San Francisco, announced Monday he’s reintroducing state legislation that would allow San Francisco to implement safe injection sites–after a similar bill was vetoed last year by Gov. Jerry Brown.”
Hepatitis C Fight Hinges on Prisons
“Lawsuits across the country are seeking better but more expensive care for inmates with the infectious disease, who can spread it upon their release.”
AASLD/IDSA HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
“The landscape of treatment for hepatitis C virus (HCV) infection has evolved substantially since the introduction of highly effective HCV protease inhibitor therapies in 2011. The pace of change has increased rapidly as numerous new drugs with different mechanisms of action have become available over the past few years.”
Comorbid Hepatitis B, Hepatitis C in New Cancer Patients Often Undetected
“A significant number of patients with newly-diagnosed cancer and concurrent hepatitis B virus (HBV) or hepatitis C virus (HCV) infection are unaware of their viral infection at the time of cancer diagnosis, according to study results published in JAMA Oncology.”
DEVELOPMENT AGAINST HEPATITIS C IS POSSIBLE BY 2030
“A complete package of screening, prevention, and treatment interventions can turn away 1.5 Million liver cancer and cirrhosis as well as 15.1 Million new hepatitis C infections deaths all over the world by end of 2030. This is equal to an 80% drop in occurrence and a 60% drop in deaths in comparison with 2015, as per the first research to model interventions of hepatitis C all over the world post in The Lancet.”
Washington state becomes the latest to embrace a Netflix model for buying hep C drugs
“The so-called Netflix payment model for obtaining hepatitis C treatments appears to be catching on among state officials as a Washington state health agency is the latest one hoping to convince drug makers to participate in such a scheme.”
Impact of Hepatitis C Virus and Insurance Coverage on Mortality
“To assess the association of payer status and mortality in hepatitis C virus (HCV)–infected patients.”
Order Educational Materials
Free brochures and materials